CN105343277A - 一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法 - Google Patents
一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法 Download PDFInfo
- Publication number
- CN105343277A CN105343277A CN201510917963.2A CN201510917963A CN105343277A CN 105343277 A CN105343277 A CN 105343277A CN 201510917963 A CN201510917963 A CN 201510917963A CN 105343277 A CN105343277 A CN 105343277A
- Authority
- CN
- China
- Prior art keywords
- parts
- folium
- extract
- herba
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 39
- 208000007712 Tinea Versicolor Diseases 0.000 title claims abstract description 38
- 206010056131 Tinea versicolour Diseases 0.000 title claims abstract description 38
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 83
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 241000717682 Anisomeles Species 0.000 claims abstract description 14
- 240000005255 Rubus parvifolius Species 0.000 claims abstract description 14
- 235000018803 Rubus parvifolius Nutrition 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 12
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 229940099259 vaseline Drugs 0.000 claims abstract description 11
- 238000001816 cooling Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 54
- 239000000843 powder Substances 0.000 claims description 48
- 201000000508 pityriasis versicolor Diseases 0.000 claims description 34
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 244000025254 Cannabis sativa Species 0.000 claims description 24
- 230000000474 nursing effect Effects 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 14
- 238000001694 spray drying Methods 0.000 claims description 14
- 238000005507 spraying Methods 0.000 claims description 14
- 210000002454 frontal bone Anatomy 0.000 claims description 13
- 208000011502 miliaria alba Diseases 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 10
- 238000000108 ultra-filtration Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 239000000919 ceramic Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 208000003251 Pruritus Diseases 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 230000007803 itching Effects 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 235000010894 Artemisia argyi Nutrition 0.000 abstract description 2
- 244000030166 artemisia Species 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000004047 Amorpha fruticosa Nutrition 0.000 abstract 1
- 240000002066 Amorpha fruticosa Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 240000006891 Artemisia vulgaris Species 0.000 abstract 1
- 235000004936 Bromus mango Nutrition 0.000 abstract 1
- 244000119298 Emblica officinalis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 235000016578 Geum urbanum Nutrition 0.000 abstract 1
- 244000308638 Geum urbanum Species 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241001480167 Lotus japonicus Species 0.000 abstract 1
- 240000007228 Mangifera indica Species 0.000 abstract 1
- 235000014826 Mangifera indica Nutrition 0.000 abstract 1
- 241000717679 Mosla Species 0.000 abstract 1
- 241000471216 Myrsine seguinii Species 0.000 abstract 1
- 241001417523 Plesiopidae Species 0.000 abstract 1
- 235000004443 Ricinus communis Nutrition 0.000 abstract 1
- 235000009184 Spondias indica Nutrition 0.000 abstract 1
- 241001251949 Xanthium sibiricum Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-N sodium;sulfuric acid Chemical compound [H+].[H+].[Na+].[O-]S([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-N 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 25
- 201000004624 Dermatitis Diseases 0.000 description 13
- 208000010668 atopic eczema Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 230000035618 desquamation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000734166 Ephebe Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 1
- 240000005616 Vigna mungo var. mungo Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 201000007162 hidradenitis suppurativa Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法,所述中药膏剂主要是由以下原料组成:热痱草、油柑叶、杧果叶、苍耳、丁香根、防风草、冰片、皂荚子、败毒草、蓖麻叶、白沙蒿、灰叶、茅莓、鹅骨梢、百脉根、鱼腥草提取物、艾叶提取物,还包括以下辅料:玄明粉、凡士林、氮酮;所述制备方法为:提取出原料药材有效成分,与辅料一起按照药学常规制药工艺制成膏剂。本发明治疗花斑糠疹的皮肤护理中药膏剂组方严谨,配伍合理,精选多味祛湿散热,杀菌消炎、凉血止痒功效的中草药,对于治疗花斑糠疹疗效显著、疗程短、见效快、使用方便,经临床验证没有任何毒副作用。
Description
技术领域
本发明涉及中药技术领域,特别是涉及一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法。
背景技术
花斑糠疹是一种由马拉色菌感染表皮角质层引起的浅表真菌病。此病表现为慢性症状,带有轻度的炎症,通常无自觉症状。损害特征为散在或融合的色素减退或色素沉着斑,症状为脱屑、掉皮、有色斑,常出现部位为胸部、背部、上臂、腋下。此病遍布世界各地,相对湿度较高的热带和温带地区发病率较高,以男青年为主,由于运动多而出汗多,更容易发生花斑糠疹。花斑糠疹还多见于应用皮质类固醇激素的人,因这类人的表皮细胞更换周期延长,有利于真菌生长,若停用激素后花斑糠疹即好转,因此复发频率高也是治疗此症的难点所在。
目前对于此病的治疗主要以西药涂抹和口服为主,主要功效是抗真菌,虽然医学技术不断发展,抗真菌性药物不断创新,但是间歇性使用西药还是不能对其彻底根除,使用频率过高也会给人的肌体带来副作用,因此需要一种既能起到抗菌消炎、祛风除湿作用,又能透过表皮渗透肌体来治疗和预防花斑糠疹的药物来解决这一难题。
发明内容
为弥补现有技术的不足,本发明提供了一种疗效好、见效快、无副作用、使用方便的治疗花斑糠疹的皮肤护理中药膏剂。
本发明的另一目的是提供一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法。
为实现上述目的,本发明的技术方案为:一种治疗花斑糠疹的皮肤护理中药膏剂,按重量组分计,主要是由以下原料组成:热痱草30-55份、油柑叶30-50份、杧果叶28-45份、冰片30-40份、苍耳30-38份、蓖麻叶22-36份、防风草24-35份、鱼腥草提取物2.5-3.2份、丁香根20-32份、灰叶18-33份、白沙蒿18-32份、艾叶提取物1.8-3.0份、皂荚子20-28份、鹅骨梢16-28份、败毒草16-24份、茅莓12-24份、百脉根13-18份。
进一步的,所述的鱼腥草提取物提取方法为:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.15-1.20的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物。
进一步的,所述的艾叶提取物提取方法为:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物。
进一步的,所述的一种治疗花斑糠疹的皮肤护理中药膏剂,按重量组分计,主要是由以下原料组成:热痱草43份、油柑叶40份、杧果叶37份、冰片35份、苍耳34份、蓖麻叶29份、防风草30份、鱼腥草提取物2.8份、丁香根26份、灰叶25份、白沙蒿25份、艾叶提取物2.4份、皂荚子24份、鹅骨梢22份、败毒草20份、茅莓18份、百脉根15份。
一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,包括以下步骤:
步骤一:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.15-1.20的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物;
步骤二:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物;
步骤三:按照上述比例称取热痱草、油柑叶、杧果叶、苍耳、蓖麻叶、防风草、丁香根、灰叶、白沙蒿、皂荚子、鹅骨梢、败毒草、茅莓、百脉根,并将所有药材置于烘箱里面烘干,烘箱设置温度55-65℃,使其水分含量低于3%,研磨成30-40目的粗粉,然后进行90-100摄氏度微波灭菌,灭菌时间100-120秒;
步骤四:给灭菌后的药材粗粉加入药材粗粉2倍重量的75%乙醇,浸泡2小时后,继续加入药材粗粉10-14倍重量的水,武火煮沸后文火煎煮2-3小时,过滤药渣得到滤液,再加入药渣4-8倍的水,武火煮沸后文火煎煮1-2小时,过滤药渣得到滤液,将两次得到的滤液混合,得到中药材提取液;
步骤五:将步骤四得到的中药材提取液经离心机5000-6000r/min离心,提取上层清液,再经过截流分子量为5000~7000的超滤柱超滤,减压浓缩得相对密度为75℃时1.24~1.35的浸膏备用;
步骤六:按照上述比例称取冰片、鱼腥草提取物、艾叶提取物,将氮酮和凡士林按重量比1:5混合熔融,然后加入步骤五得到的浸膏、玄明粉溶液、冰片、鱼腥草提取物、艾叶提取物混合均匀并搅拌成膏状,所述的氮酮、凡士林、玄明粉溶液、浸膏重量比为1:5:3:3,冷却后包装即制成膏剂。
本发明各中药原料的药理活性如下:
热痱草:发表祛暑;利湿和中;消肿止血;散风止痒。主风寒感冒;阴暑头痛;恶心;脘痛;白痢;水肿;衄血;痔血;疮疖;阴痒;湿疹;痱毒;外伤出血;蛇虫咬伤。
油柑叶:治皮肤湿疹,疔疮,痔漏。
杧果叶:止痒。外用治湿疹瘙痒。
苍耳:祛风散热,解毒杀虫。治头风,头晕,湿痹拘挛,目赤、目翳,风癞,疔肿,热毒疮疡,皮肤瘙痒。
丁香根:散热解毒。主风热肿毒。
防风草:祛风,除湿,解毒。治感冒身热,呕吐,腹痛,筋骨疼痛,疮疡,湿疹,痔疾。
冰片:开窍醒神;散热止痛;明目去翳。主中风口噤;热病神昏;惊痫痰迷;气闭耳聋;目赤翳膜;喉痹;口疮;痈肿;痔疮;蛲虫病。
皂荚子:润肠通便;祛风散热;化痰散结。主大便燥结;肠风下血;痢疾里急后重;痰喘肿满;疝气疼痛;瘰疬;肿毒;疮癣。
败毒草:解毒止痒。主治风毒疮痒。
蓖麻叶:消肿拔毒,止痒。治疮疡肿毒,鲜品捣烂外敷;治湿疹搔痒,煎水外洗;并可灭蛆、杀孑孓。
白沙蒿:消炎散瘀,利气,杀虫。
灰叶:解表,健脾燥湿,行气止痛。用于风热感冒,消化不良,腹胀腹痛,慢性胃炎;外用治湿疹,皮炎。
茅莓:清热凉血,散结,止痛,利尿消肿。用于感冒发热,咽喉肿痛,咯血,吐血,痢疾,肠炎,肝炎,肝脾肿大,肾炎水肿,泌尿系感染,结石,月经不调,白带,风湿骨痛,跌打肿痛;外用治湿疹,皮炎。
鹅骨梢:清热解毒,凉血,祛湿。治乳腺炎初起。外用治湿疹,疮疖。
百脉根:清热解毒,止咳平喘。用于风热咳嗽,咽炎,扁桃体炎,胃中痞满疼痛;外用治湿疹,疮疖,痔疮。
鱼腥草提取物:清热解毒,消痈排脓,利尿通淋。用于肺痈吐脓,痰热喘咳,热痢,热淋,痈肿疮毒。
艾叶提取物:散寒止痛,温经止血。用于少腹冷痛,经寒不调,宫冷不孕,吐血,衄血,崩漏经多,妊娠下血;外治皮肤瘙痒。醋艾炭温经止血。用于虚寒性出血。
与现有技术相比,本发明的有益效果体现在:通过精选多种中草药及中草药提取物,能够有效的起到祛风除湿、清洁皮肤、抗菌消炎的作用,更能调节皮肤代谢,使皮肤快速的吸收,既能治疗花斑糠疹,长期配合水洗也能很好的起到预防的作用,无毒副作用,使用方便。
具体实施方式
下面结合具体实施方式对本发明进行进一步详细的说明:
实施例1:一种治疗花斑糠疹的皮肤护理中药膏剂,按重量组分计,主要是由以下原料组成:热痱草30份、油柑叶30份、杧果叶28份、冰片30份、苍耳30份、蓖麻叶22份、防风草24份、鱼腥草提取物2.5份、丁香根20份、灰叶18份、白沙蒿18份、艾叶提取物1.8份、皂荚子20份、鹅骨梢16份、败毒草16份、茅莓12份、百脉根13份。
一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,包括以下步骤:
步骤一:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.15的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物;
步骤二:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物;
步骤三:按照上述比例称取热痱草、油柑叶、杧果叶、苍耳、蓖麻叶、防风草、丁香根、灰叶、白沙蒿、皂荚子、鹅骨梢、败毒草、茅莓、百脉根,并将所有药材置于烘箱里面烘干,烘箱设置温度55℃,使其水分含量低于3%,研磨成30目的粗粉,然后进行90摄氏度微波灭菌,灭菌时间100秒;
步骤四:给灭菌后的药材粗粉加入药材粗粉2倍重量的75%乙醇,浸泡2小时后,继续加入药材粗粉10倍重量的水,武火煮沸后文火煎煮2小时,过滤药渣得到滤液,再加入药渣4倍的水,武火煮沸后文火煎煮1小时,过滤药渣得到滤液,将两次得到的滤液混合,得到中药材提取液;
步骤五:将步骤四得到的中药材提取液经离心机5000r/min离心,提取上层清液,再经过截流分子量为5000的超滤柱超滤,减压浓缩得相对密度为75℃时1.24的浸膏备用;
步骤六:按照上述比例称取冰片、鱼腥草提取物、艾叶提取物,将氮酮和凡士林按重量比1:5混合熔融,然后加入步骤五得到的浸膏、玄明粉溶液、冰片、鱼腥草提取物、艾叶提取物混合均匀并搅拌成膏状,所述的氮酮、凡士林、玄明粉溶液、浸膏重量比为1:5:3:3,冷却后包装即制成膏剂。
实施例2:一种治疗花斑糠疹的皮肤护理中药膏剂,按重量组分计,主要是由以下原料组成:热痱草43份、油柑叶40份、杧果叶37份、冰片35份、苍耳34份、蓖麻叶29份、防风草30份、鱼腥草提取物2.8份、丁香根26份、灰叶25份、白沙蒿25份、艾叶提取物2.4份、皂荚子24份、鹅骨梢22份、败毒草20份、茅莓18份、百脉根15份、。
一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,包括以下步骤:
步骤一:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.175的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物;
步骤二:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物;
步骤三:按照上述比例称取热痱草、油柑叶、杧果叶、苍耳、蓖麻叶、防风草、丁香根、灰叶、白沙蒿、皂荚子、鹅骨梢、败毒草、茅莓、百脉根,并将所有药材置于烘箱里面烘干,烘箱设置温度60℃,使其水分含量低于3%,研磨成35目的粗粉,然后进行95摄氏度微波灭菌,灭菌时间110秒;
步骤四:给灭菌后的药材粗粉加入药材粗粉2倍重量的75%乙醇,浸泡2小时后,继续加入药材粗粉12倍重量的水,武火煮沸后文火煎煮2.5小时,过滤药渣得到滤液,再加入药渣6倍的水,武火煮沸后文火煎煮1.5小时,过滤药渣得到滤液,将两次得到的滤液混合,得到中药材提取液;
步骤五:将步骤四得到的中药材提取液经离心机5500r/min离心,提取上层清液,再经过截流分子量为6000的超滤柱超滤,减压浓缩得相对密度为75℃时1.30的浸膏备用;
步骤六:按照上述比例称取冰片、鱼腥草提取物、艾叶提取物,将氮酮和凡士林按重量比1:5混合熔融,然后加入步骤五得到的浸膏、玄明粉溶液、冰片、鱼腥草提取物、艾叶提取物混合均匀并搅拌成膏状,所述的氮酮、凡士林、玄明粉溶液、浸膏重量比为1:5:3:3,冷却后包装即制成膏剂。
实施例3:一种治疗花斑糠疹的皮肤护理中药膏剂,按重量组分计,主要是由以下原料组成:热痱草55份、油柑叶50份、杧果叶45份、冰片40份、苍耳38份、蓖麻叶36份、防风草35份、鱼腥草提取物3.2份、丁香根32份、灰叶33份、白沙蒿32份、艾叶提取物3.0份、皂荚子28份、鹅骨梢28份、败毒草24份、茅莓24份、百脉根18份、。
一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,包括以下步骤:
步骤一:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.20的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物;
步骤二:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物;
步骤三:按照上述比例称取热痱草、油柑叶、杧果叶、苍耳、蓖麻叶、防风草、丁香根、灰叶、白沙蒿、皂荚子、鹅骨梢、败毒草、茅莓、百脉根,并将所有药材置于烘箱里面烘干,烘箱设置温度65℃,使其水分含量低于3%,研磨成40目的粗粉,然后进行100摄氏度微波灭菌,灭菌时间120秒;
步骤四:给灭菌后的药材粗粉加入药材粗粉2倍重量的75%乙醇,浸泡2小时后,继续加入药材粗粉14倍重量的水,武火煮沸后文火煎煮3小时,过滤药渣得到滤液,再加入药渣8倍的水,武火煮沸后文火煎煮2小时,过滤药渣得到滤液,将两次得到的滤液混合,得到中药材提取液;
步骤五:将步骤四得到的中药材提取液经离心机6000r/min离心,提取上层清液,再经过截流分子量为7000的超滤柱超滤,减压浓缩得相对密度为75℃时1.35的浸膏备用;
步骤六:按照上述比例称取冰片、鱼腥草提取物、艾叶提取物,将氮酮和凡士林按重量比1:5混合熔融,然后加入步骤五得到的浸膏、玄明粉溶液、冰片、鱼腥草提取物、艾叶提取物混合均匀并搅拌成膏状,所述的氮酮、凡士林、玄明粉溶液、浸膏重量比为1:5:3:3,冷却后包装即制成膏剂。
临床试验:
1.临床病例选择
1.1选择标准:花斑糠疹出现在胸部、背部、颈部、面部、腋部、腹部、肩部及上臂等处。
1.2选择并分组:发明人共收集150例患花斑糠疹的门诊患者,随机分为三组,每组50人,三组性别、年龄、病情等资料均无显著性差异,具有可比性。
2.试验方法:分别给三组患者患处使用实施例1、实施例2、实施例3制备的中药膏剂,每天涂抹2次,10天为一个疗程。
3.疗效标准与治疗结果
3.1疗效标准
(1)痊愈:临床症状完全消失;
(2)显效:临床症状明显改善,创面明显减小,皮肤代谢正常;
(3)无效:症状无改善,或有加重趋势。
3.2治疗统计结果
表1—三组疗效比较
服用的药物 | 病例人数 | 痊愈 | 显效 | 无效 | 不良反应 | 总有效率% |
实施例1 | 50 | 32 | 11 | 7 | 0 | 86.0 |
实施例2 | 50 | 38 | 8 | 4 | 0 | 92.0 |
实施例3 | 50 | 35 | 9 | 6 | 0 | 88.0 |
4.结论:临床试验过程中,接受本发明药物治疗的患者未发现有任何不良反应,由表1数据可见,本发明药物对花斑糠疹的总有效率达86.0%以上,是治疗花斑糠疹的安全有效药物,具有很好的临床意义。
5.临床个体病例
病例1:张某,男,35岁,建筑工人,因为长期在较湿热环境中工作,饮食习惯单一,住宿环境差,背部出现掉干皮并偶尔发痒症状已经3年多,当发痒难以忍受时就涂抹些西药,但药停以后立即复发,使用本发明实施例1制备的治疗花斑糠疹的皮肤护理中药膏剂一个疗程后,脱皮现象消失,没有出现发痒症状,使用两个疗程以后,患处和正常皮肤已无差别,半年内随访,未复发。
病例2:彭某某,女,55岁,肩部出现脱屑掉干皮症状半年,无发痒症状,偶尔伴有红色斑点出现,口服过敏药物和涂抹西药制剂,症状减轻,但没有彻底治愈,使用本发明实施例2制备的治疗花斑糠疹的皮肤护理中药膏剂一个疗程后脱屑症状消失,继续使用一个疗程后痊愈,三个月内未复发。
病例3:王某某,女,29岁,腹部皮肤有湿疹,一周后出现掉皮症状,使用本发明实施例3制备的治疗花斑糠疹的皮肤护理中药膏剂,一个疗程后,无过敏反应,湿疹减少,2周后,掉皮症状消失,皮肤光滑。
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明实施例技术方案的精神和范围。
Claims (8)
1.一种治疗花斑糠疹的皮肤护理中药膏剂,其特征在于,按重量组分计,主要是由以下原料组成:热痱草30-55份、油柑叶30-50份、杧果叶28-45份、冰片30-40份、苍耳30-38份、蓖麻叶22-36份、防风草24-35份、鱼腥草提取物2.5-3.2份、丁香根20-32份、灰叶18-33份、白沙蒿18-32份、艾叶提取物1.8-3.0份、皂荚子20-28份、鹅骨梢16-28份、败毒草16-24份、茅莓12-24份、百脉根13-18份。
2.如权利要求1所述的一种治疗花斑糠疹的皮肤护理中药膏剂,其特征在于,所述的鱼腥草提取物提取方法为:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.15-1.20的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物。
3.如权利要求1所述的一种治疗花斑糠疹的皮肤护理中药膏剂,其特征在于,所述的艾叶提取物提取方法为:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物。
4.如权利要求1所述的一种治疗花斑糠疹的皮肤护理中药膏剂,其特征在于,按重量组分计,主要是由以下原料组成:热痱草43份、油柑叶40份、杧果叶37份、冰片35份、苍耳34份、蓖麻叶29份、防风草30份、鱼腥草提取物2.8份、丁香根26份、灰叶25份、白沙蒿25份、艾叶提取物2.4份、皂荚子24份、鹅骨梢22份、败毒草20份、茅莓18份、百脉根15份。
5.如权利要求1-4所述的一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,其特征在于,包括以下步骤:
步骤一:将鱼腥草原料在烘箱烘干,烘箱设置温度60℃,粉碎后,加入10倍量的水,加热至100℃煎煮2小时,过滤,滤渣再按照上述操作提取2次,然后合并3次的提取液,将提取液减压浓缩并蒸发水分至比重为d=1.15-1.20的浸膏,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,过100目筛,得到的棕黄色粉末即为鱼腥草提取物;
步骤二:将艾叶、水、乙醇按照质量比1:8:3混合,所述乙醇质量浓度为60%,加热回流提取三次,提取温度为80℃,每次提取2小时,合并提取液,提取液经浓缩回收乙醇,蒸发水分,使用喷雾干燥塔进行喷雾干燥制成浸膏粉,120目过筛,得到的棕色粉末即为艾叶提取物;
步骤三:按照上述比例称取热痱草、油柑叶、杧果叶、苍耳、蓖麻叶、防风草、丁香根、灰叶、白沙蒿、皂荚子、鹅骨梢、败毒草、茅莓、百脉根,并将所有药材置于烘箱里面烘干,使其水分含量低于3%,研磨成30-40目的粗粉,然后进行90-100℃微波灭菌,灭菌时间100-120秒;
步骤四:给灭菌后的药材粗粉加入乙醇,浸泡2小时后,继续加入药材粗粉10-14倍重量的水,武火煮沸后文火煎煮2-3小时,过滤药渣得到滤液,再加入药渣4-8倍的水,武火煮沸后文火煎煮1-2小时,过滤药渣得到滤液,将两次得到的滤液混合,得到中药材提取液;
步骤五:将步骤四得到的中药材提取液经离心机5000-6000r/min离心,提取上层清液,再经过截流分子量为5000~7000的超滤柱超滤,减压浓缩得相对密度为75℃时1.24~1.35的浸膏备用;
步骤六:按照上述比例称取冰片、鱼腥草提取物、艾叶提取物,将氮酮和凡士林按重量比1:5混合熔融,然后加入步骤五得到的浸膏、玄明粉溶液、冰片、鱼腥草提取物、艾叶提取物混合均匀并搅拌成膏状,所述的氮酮、凡士林、玄明粉溶液、浸膏重量比为1:5:3:3,冷却后包装即制成膏剂。
6.如权利要求5中所述的一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,其特征在于步骤一中所述的烘箱温度设置为55-65℃。
7.如权利要求5中所述的一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,其特征在于步骤四中所述的乙醇质量浓度为75%,加入量为药材粗粉重量的2倍。
8.如权利要求5所述的一种治疗花斑糠疹的皮肤护理中药膏剂的制备方法,其特征在于步骤六中所述的的玄明粉溶液是将玄明粉与水按照质量比1:2混合,使玄明粉充分化开后制备而成的。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510917963.2A CN105343277A (zh) | 2015-12-11 | 2015-12-11 | 一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510917963.2A CN105343277A (zh) | 2015-12-11 | 2015-12-11 | 一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105343277A true CN105343277A (zh) | 2016-02-24 |
Family
ID=55319435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510917963.2A Pending CN105343277A (zh) | 2015-12-11 | 2015-12-11 | 一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105343277A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110559552A (zh) * | 2019-09-18 | 2019-12-13 | 郑州伊品医药科技有限公司 | 一种男士养护保健垫及其制备方法 |
CN114344355A (zh) * | 2021-12-09 | 2022-04-15 | 深圳安卓幸制药有限公司 | 一种防风草入药的提取方法 |
-
2015
- 2015-12-11 CN CN201510917963.2A patent/CN105343277A/zh active Pending
Non-Patent Citations (1)
Title |
---|
高希言: "《疗效神奇的熏疗》", 30 November 2011, 中原出版传媒集团等 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110559552A (zh) * | 2019-09-18 | 2019-12-13 | 郑州伊品医药科技有限公司 | 一种男士养护保健垫及其制备方法 |
CN114344355A (zh) * | 2021-12-09 | 2022-04-15 | 深圳安卓幸制药有限公司 | 一种防风草入药的提取方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102319350B (zh) | 一种用于治疗烧、烫伤的外用烫伤油药物组合物 | |
CN106421663A (zh) | 一种治疗风湿骨病的药物组合物及其制备方法 | |
CN103272149B (zh) | 一种防治肛肠病手术后并发症的药物组合物 | |
CN106074752A (zh) | 一种治疗骨病的外用中药组合物 | |
CN104338083A (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN101167999A (zh) | 热敷熥及其制备方法 | |
CN103816504A (zh) | 一种活血止痛膏及其制备方法 | |
CN102772591B (zh) | 一种治疗鼻炎的中空、通气、双层中药栓剂及其制作方法 | |
CN106214752A (zh) | 一种治疗跌打损伤、骨折中药组合物及其制备方法 | |
CN102008610B (zh) | 一种治疗骨质增生的中药组合物 | |
CN105343277A (zh) | 一种治疗花斑糠疹的皮肤护理中药膏剂及其制备方法 | |
CN102813900A (zh) | 一种治疗脚鸡眼的外用药 | |
CN104873766A (zh) | 一种治疗鼻炎的药物组合物及其制备方法 | |
CN103908600A (zh) | 治疗类风湿性关节炎湿热痹阻证的外用药物、制备方法及给药方式 | |
CN103495085A (zh) | 一种治疗放射性皮炎的中药制剂 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN104815029B (zh) | 一种治疗足癣的药物及其制备方法 | |
CN104189345A (zh) | 治疗疼痛病的外用中药膏药 | |
CN103386010B (zh) | 一种治疗疮疡的药物及其制备方法 | |
CN108114220A (zh) | 一种治疗鼻炎的胶囊剂药物及制备方法 | |
CN110013513B (zh) | 一种治疗风湿骨痛的外用凝胶及其制备方法 | |
CN105168945A (zh) | 一种用于促进骨折愈合的外用药膏及制备方法 | |
CN105288158A (zh) | 一种治疗寒湿型慢性鼻炎的中药 | |
CN100413516C (zh) | 治疗骨折的中药制剂及其制备方法 | |
CN104491004A (zh) | 一种鼻炎膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |